Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24028677 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.
Condition: Asthma
Intervention: Drug: omalizumab

Indicates status has not been verified in more than two years